Amphastar Pharmaceuticals, Inc.AMPH
Close of Friday, October 23, 2026 · Amphastar Pharmaceuticals, Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$25.14
vs its Pivot
+12.8%
OnlyAlpha Score
48
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -4.3% | -6.1% | +2.5% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Suppliers, customers and partners
Sells to AMPH
| Eli Lilly | BAQSIMI transition services |
AMPH sells to
| McKesson | 24% of net revenues |
| Cencora | 22% of net revenues |
| Cardinal Health | 19% of net revenues |
From the companies' own annual reports filed with the SEC.
Get AMPH in your free daily emailAfter every close: whether AMPH is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track AMPH free → Full Stock check
Track AMPH free → Full Stock check